Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Abbott isolates fusacandin antifungal agents

Jan. 20, 1997

Daikin synthesizes new ganglioside compounds

Jan. 20, 1997

Pfizer reports new GH stimulants

Jan. 17, 1997

Pfizer investigates beta-adrenoceptor agonists

Jan. 17, 1997

Immunotherapeutic vaccine for CML reported in patent literature

Jan. 17, 1997

Merck & Co. claims FPTase inhibitors for cancer

Jan. 17, 1997

Therapeutically active glycomimetic saccharopeptides from Glycomed

Jan. 17, 1997

Terumo prepares smooth muscle cell proliferation inhibitors

Jan. 17, 1997

Hypoglycemic agents from Nippon Chemiphar

Jan. 17, 1997

Novel antioxidant disclosed by Nippon Chemiphar

Jan. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.